| Literature DB >> 25874115 |
Lei Zuo1, Haidong Zou2, Xinfeng Fei1, Weiqi Xu1, Jianhong Zhang1.
Abstract
In the current study, the CLVQOL was used to assess VRQOL before unilateral or bilateral cataract surgery and at the end of the follow-up period in order to determine the greater beneficial mode of surgery for patients, if one of the two surgical methods is more beneficial over the other. The patients were classified as receiving unilateral (group A) and bilateral cataract surgery (group B). There were no significant differences between groups A and B before the operation in terms of life quality scores, binocular weighted average LogMAR BCVA, age, educational level, gender, systematic and ocular comorbidities, and the complications of the operation. It was shown that visual acuity improved more significantly with bilateral cataract surgery than with unilateral surgery in elderly patients with a high preoperative disease burden in Shanghai city. However, the improvement in life quality was not different in patients receiving either bilateral or unilateral cataract surgery.Entities:
Year: 2015 PMID: 25874115 PMCID: PMC4385650 DOI: 10.1155/2015/509049
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Clinical characteristics compared in unilateral and bilateral cataract extraction patients.
| Unilateral cataract extraction patients | Bilateral cataract extraction patients |
| Statistical methods | |
|---|---|---|---|---|
| Age (SD) (year) | 74.38 (10.82) | 72.57 (9.29) | 0.477 | Independent samples |
| Educational time (SD) (year) | 7.88 (3.80) | 8.80 (3.60) | 0.328 | Independent samples |
| Gender (male, female) | 66, 87 | 67, 78 | 0.594 | Pearson chi-square test |
| Ocular comorbidities (%) | 84 (54.9) | 80 (55.2) | 0.963 | Pearson chi-square test |
| Systemic comorbidities (%) | 84 (54.9) | 85 (58.6) | 0.517 | Pearson chi-square test |
| Surgical complications (%) | 10 (6.5) | 9 (6.2) | 0.907 | Pearson chi-square test |
Ocular comorbidities, systemic comorbidities, and surgical complications in patients receiving either unilateral or bilateral cataract extraction, * P < 0.05 and ** 0.05 < P < 0.10.
| Number (%) |
| ||
|---|---|---|---|
| Unilateral cataract extraction patients | Bilateral cataract extraction patients | ||
| Ocular comorbidity | |||
| Age-related macular degeneration | 11 (7.2%) | 12 (8.3%) | 0.136/0.712 |
| Pathologic myopia | 20 (13.1%) | 16 (11.0%) | 0.291/0.590 |
| Glaucoma | 21 (13.7%) | 31 (21.4%) | 2.836/0.092** |
| Surgery history of scleral buckling and/or vitrectomy | 13 (8.5%) | 3 (2.1%) | 6.054/0.014* |
| Pathologic myopia and surgery history of scleral buckling and/or vitrectomy | 11 (7.2%) | 10 (6.9%) | 0.010/0.921 |
| Diabetic retinopathy | 2 (1.3%) | 7 (4.8%) | 3.150/0.076** |
| Other | 6 (3.9%) | 1 (0.7%) | 3.390/0.066** |
|
| |||
| Systemic comorbidity | |||
| Hypertension | 37 (24.2%) | 37 (25.5%) | 0.071/0.790 |
| Diabetes mellitus | 5 (3.3%) | 11 (7.6%) | 2.732/0.098** |
| Hypertension and diabetes mellitus | 22 (14.4%) | 18 (12.4%) | 0.247/0.619 |
| Cardiopathy | 8 (5.2%) | 11 (7.6%) | 0.693/0.405 |
| Respiratory | 5 (3.3%) | 3 (2.1%) | 0.410/0.522 |
| Other | 7 (4.6%) | 1 (0.7%) | 4.302/0.038* |
|
| |||
| Surgical complication | |||
| Vitreous loss | 5 (3.3%) | 4 (2.8%) | 0.066/0.797 |
| Iris atrophy | 3 (2.0%) | 3 (2.1%) | 0.004/0.947 |
| Anisometropia | 1 (0.7%) | 2 (1.4%) | 0.393/0.531 |
| Opacification of anterior capsule | 1 (0.7%) | 0 (0%) | 0.951/0.329 |
Comparison of VRQOL score and weighted average LogMAR BCVA in patients undergoing either unilateral or bilateral cataract extraction, * P < 0.05.
| Unilateral cataract extraction patients | Bilateral cataract extraction patients |
| |
|---|---|---|---|
| Preoperative VRQOL score (SD) | 77.02 (30.08) | 71.85 (25.24) | 0.175 |
| 3-month postoperative VRQOL score (SD) | 100.32 (20.95) | 102.55 (17.65) | 0.731 |
| The improvement of VRQOL score (SD) | 23.26 (17.89) | 30.89 (25.78) | 0.112 |
| Preoperative weighted average LogMAR BCVA (SD) | 0.76 (0.62) | 0.86 (0.44) | 0.137 |
| 3-month postoperative weighted average LogMAR BCVA (SD) | 0.36 (0.36) | 0.26 (0. 24) | 0.242 |
| The improvement of weighted average LogMAR BCVA (SD) | 0.40 (0.37) | 0.59 (0.44) | 0.024* |
Effects of systemic comorbidities, ocular comorbidities, surgical complications, and gender on the improvement of VRQOL score at the end of follow-up period (* P < 0.05, ** 0.05 < P < 0.10).
| Unilateral cataract extraction patients | Bilateral cataract extraction patients | All cataract extraction patients | ||||
|---|---|---|---|---|---|---|
| Mean improvement in score (SD) |
| Mean improvement in score (SD) |
| Mean improvement in score (SD) |
| |
| With systemic comorbidities | 25.00 (17.89) | 0.671 | 47.64 (30.58) | 0.158 | 35.83 (26.80) | 0.149 |
| Without systemic comorbidities | 24.05 (18.89) | 26.89 (28.18) | 25.40 (23.49) | |||
| With ocular comorbidities | 21. 60 (19.31) | 0.550 | 25.94 (35.07) | 0.094** | 24.33 (29.84) | 0.135 |
| Without ocular comorbidities | 25.61 (18.07) | 45.69 (18.45) | 32.86 (20.44) | |||
| With surgical complication | 7.60 (10.60) | 0.019* | 11.00 (23.45) | 0.094** | 9.11 (16.30) | 0.006* |
| Without surgical complication | 27.39 (17.78) | 38.12 (29.96) | 32.56 (24.78) | |||
| Female | 25.12 (16.87) | 0.763 | 30.93 (32.39) | 0.412 | 27.84 (25.09) | 0.655 |
| Male | 23.63 (20.13) | 38.07 (28.75) | 30.61 (25.34) | |||
Multiple impact factors that influence the improvement in VRQOL score at the end of the follow-up period (3 months after cataract surgery) (* P < 0.05, ** 0.05 < P < 0.10).
| Unilateral cataract surgery patients | Bilateral cataract surgery patients | All cataract surgery patients | |
|---|---|---|---|
| Preoperative VRQOL score | −0.367/0.030* | −0.823/0.000* | −0.679/0.000* |
| Preoperative weighted average LogMAR BCVA | −0.085/0.802 | 0.055/0.730 | −0.554/0.001* |
| Weighted average LogMAR BCVA change | 0.461/0.008* | 0.278/0.053** | 0.731/0.000* |
| Age | 0.088/0.559 | 0.172/0.176 | 0.113/0.193 |
| Educational time | 0.196/0.116 | −0.109/0.323 | 0.019/0.806 |
| Unilateral or bilateral surgery | / | / | 1.220/0.062** |
| With or without surgical complication | −2.015/0.098** | −1.802/0.237 | −2.190/0.015* |
| With or without systemic comorbidities | −0.045/0.955 | 1.902/0.133 | 0.664/0.302 |
| With or without ocular comorbidities | −1.049/0.211 | −2.615/0.041* | −1.550/0.017* |